Welcome to the Desert Angels™. We are a Tucson, Arizona based non-profit organization of accredited investors who seek opportunities to invest in Southwest regional startup or early stage companies. The organization serves as a forum for its over 100 members, who invest individually from their personal funds. Since 2000, Desert Angel members have invested over $34 million in more than 80 presenting companies.

FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart

by gabrielsayegh on March 31st, 2015 at 4:35pm

Desert Angels portfolio company, SynCardia Systems, Inc. has received FDA approval to launch an Investigational Device Exemption study into the effective use of the new 50cc SynCardia Heart. The 50cc heart is the smaller version of the 70cc SynCardia Heart, which is FDA, Health Canada and CE mark approved. It is designed for implantation in most women, smaller men and many adolescents with end-stage biventricular heart failure.

Click here for full article

Comment

How a mutated gene receptor and stem cell technology could lead to a cure for HIV

by gabrielsayegh on February 4th, 2015 at 4:53pm

One of Desert Angels’ prominent portfolio companies, Calimmune, has announced it is about to move on to the second half of its Phase 1 human trial, and will soon implant four new patients with its genetically modified stem cells.

Click here for full article

Comment

Filed under: Funded Companies

Two Tucson firms among 6 innovation grant winners

by gabrielsayegh on February 4th, 2015 at 4:24pm

The Arizona Commerce Authority announced the six winning companies in its Fall 2014 Arizona Innovation Challenge on Tuesday, and two are from Tucson, including Desert Angels portfolio company, NuvO Pharma.

Click here for the full article

Comment

Filed under: Funded Companies

Tucson’s SynCardia wins OK for key heart study

by gabrielsayegh on January 10th, 2015 at 3:50pm

Desert Angels portfolio company, Tucson-based SynCardia Systems Inc. has received approval from the U.S. Food and Drug Administration to conduct a clinical study of the company’s temporary Total Artificial Heart for permanent use as so-called “destination therapy.” The FDA approved an Investigational Device Exemption application to allow SynCardia to study the heart’s use in 19 patients who do not qualify for a donor heart transplant.

Click here for the full article

Comment

Filed under: Funded Companies

HTG Molecular Diagnostics Files for IPO of up to $60M

by gabrielsayegh on January 7th, 2015 at 3:45pm

Desert Angels portfolio company, HTG Molecular Diagnostics, has filed a prospectus for an initial public offering of its stock for up to $60 million. The Tucson, Ariz.-based firm has not priced its shares nor said how many shares it plans to offer. It said in its Form S-1 filed with the US Securities and Exchange Commission on Tuesday that it plans to trade its stock on the Nasdaq Global Market under the ticker symbol “HTGM.” Leerink Partners, Canaccord Genuity, and JMP Securities are listed as the offering’s underwriters.

Click here for the full article.

Comment

Filed under: Funded Companies

Stimwave Receives FDA Clearance for World’s First Injectable Wireless MicroSize Pain Relief System for Chronic Back and Leg Pain

by gabrielsayegh on December 8th, 2014 at 5:28pm

Desert Angels portfolio company, Stimwave Technologies Incorporated; a medical device manufacturer and independent research institute headquartered in Miami Beach, Fla., has received FDA clearance to market the world’s first wireless, microtechnology neuromodulation device for relief of chronic back and leg pain. Currently being marketed throughout Europe, Stimwave announced it’s revolutionary electroceutical device will be commercially available in the U.S. as of January 2015.

Click here for the full article

1 comment

Picmonic receives $1.25 million in financing from local investors

by gabrielsayegh on November 12th, 2014 at 5:50pm

Desert Angels portfolio company, Picmonic; the Tempe-based company  which develops audiovisual study cards for medical students, has closed on $1.25 million in financing from local investors. Picmonic CEO and co-founder Ron Robertson said the money will help support the company’s move into the mobile industry and open up new markets in education. This financing, which closed in September, brings the company’s total money raised to $2.6 million.

Click here for the full article

Comment

Filed under: Funded Companies

HTG Molecular Diagnostics Announces $16 Million Term Loan Agreement With Silicon Valley Bank and Oxford Finance

by gabrielsayegh on August 30th, 2014 at 8:41pm

Desert Angels portfolio company, HTG Molecular Diagnostics, announced that it has closed a growth capital term loan facility with Silicon Valley Bank and Oxford Finance. The loan facility provides HTG with up to $16 million of available proceeds, with $11 million funded at the initial closing this month.

For More: HTG Molecular Diagnostics Announces $16 Million Term Loan Agreement With Silicon Valley Bank and Oxford Finance

Comment

Gaming for good—with celebrities

by gabrielsayegh on August 30th, 2014 at 8:34pm

Fortune Magazine reported that Desert Angels portfolio company, Tiltify, capitalizes on livestreaming and opens up opportunities for celebrities, athletes and gamers to play for good causes.

For more: Gaming for good—with celebrities

Comment

Filed under: Funded Companies

Stem cell therapy could lead to HIV cure

by Curtis Gunn on August 7th, 2014 at 4:03pm

Desert Angels portfolio company Calimmune is recognized for being at the forefont of developing a practical cure for people living with HIV infection.

Special note: The article erroneously credits the company as a San Diego based company – Calimmune is a Tucson based company.

For more: Stem cell therapy could lead to HIV cure

Comment

Filed under: Funded Companies, Press